Dose Ranging Study of Pazopanib to Treat Neovascular Age-Related Macular Degeneration
Status:
Completed
Trial end date:
2012-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety and efficacy of different dosage
regimens of pazopanib eye drops for the treatment of neovascular age-related macular
degeneration.